INVENTIVA SA - ADR
IVA · NASDAQ
Updated at 2026-10-13 15:28:33
- Today's High
- $3.03
- Today’s Low
- $2.91
%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23150%3B%26%23135%3B%26%23230%3B%26%23161%3B%26%23163%3B%26%23230%3B%26%23154%3B%26%23151%3B%26%23232%3B%26%23167%3B%26%23146%3B%22%20d%3D%22M48.3363%2013.4132H60.2082L46.795%205.72205e-06V11.8719C46.795%2012.7231%2047.4851%2013.4132%2048.3363%2013.4132Z%22%20fill%3D%22var(--fill-0%2C%20%23474741)%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23148%3B%26%23190%3B%26%23229%3B%26%23164%3B%26%23167%3B%26%23233%3B%26%23149%3B%26%23156%3B%22%20fill-rule%3D%22evenodd%22%20clip-rule%3D%22evenodd%22%20d%3D%22M11.3812%2020.3725C16.7977%2014.9559%2025.5803%2014.9559%2030.9969%2020.3725C36.413%2025.789%2036.4131%2034.5707%2030.9969%2039.9872C26.0109%2044.973%2018.1729%2045.3699%2012.7335%2041.1769L2.54298%2051.3684L0%2048.8254L10.1915%2038.6329C5.99993%2033.1937%206.39609%2025.3579%2011.3812%2020.3725ZM28.4539%2022.9155C24.4418%2018.9033%2017.9363%2018.9033%2013.9241%2022.9155C9.91245%2026.9275%209.91241%2033.4322%2013.9241%2037.4442C17.9362%2041.4562%2024.4418%2041.4562%2028.4539%2037.4442C32.4656%2033.4322%2032.4656%2026.9275%2028.4539%2022.9155Z%22%20fill%3D%22var(--fill-0%2C%20%235D5D56)%22%2F%3E%0A%3C%2Fg%3E%0A%20%20%3C%2Fsvg%3E%0A%3C%2Fsvg%3E%0A)
Candlestick trends are for reference. Refer to the trading page for actual data.
Key Statistics
- Previous Open
- $3.25
- Previous Close
- $3.12
- Volume
- 3.26M
- Market Cap
- $680.51M
- P/E Ratio
- --
- EPS
- $-2.28
Previous Day Range
52-Week Range
Company Overview
- Sector
- HEALTHCARE
- Industry
- Biotechnology
- Sub-industry
- BIOTECHNOLOGY
- Headquarters
- 50 RUE DE DIJON, DAIX, FRANCE, 21121
- Country
- FR
- Listing Date
- 2017-02-15
- Fiscal Year End
- December
- Shares Outstanding
- 236.28M
- CIK
- 0001756594
- Website
- inventivapharma.com
Inventiva SA, a clinical-stage biopharmaceutical company, focuses on the development of oral small molecule therapies for the treatment of non-alcoholic steatohepatitis (NASH), mucopolysaccharidosis (MPS) and other diseases. The company is headquartered in Daix, France.
Financial Metrics
Revenue
2026-06-30
$1.3M
2026-03-31
$28.78K
2025-12-31
$28.78K
2025-06-30
$4.45M
Operating Expenses
2026-06-30
$71.23M
2026-03-31
$77.76M
2025-12-31
$77.76M
2025-06-30
$59.55M
Net Income
2026-06-30
-$70.4M
2026-03-31
-$176.93M
2025-12-31
-$176.93M
2025-06-30
-$175.88M
Net Profit Margin
2026-06-30
-5.39K%
2026-03-31
-614.68K%
2025-12-31
-614.68K%
2025-06-30
-3.94K%
Earnings Per Share
2026-06-30
--
2026-03-31
$0.00
2025-12-31
$0.00
2025-06-30
$-1.62
Earnings Before Interest, Taxes, Depreciation, and Amortization
2026-06-30
-$70.7M
2026-03-31
-$77.73M
2025-12-31
-$77.73M
2025-06-30
-$165.84M
Effective Tax Rate
2026-06-30
-0.14%
2026-03-31
0.37%
2025-12-31
0.37%
2025-06-30
0.91%
| Item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-06-30 |
|---|---|---|---|---|
| Revenue | $1.3M | $28.78K | $28.78K | $4.45M |
| Operating Expenses | $71.23M | $77.76M | $77.76M | $59.55M |
| Net Income | -$70.4M | -$176.93M | -$176.93M | -$175.88M |
| Net Profit Margin | -5.39K% | -614.68K% | -614.68K% | -3.94K% |
| Earnings Per Share | -- | $0.00 | $0.00 | $-1.62 |
| Earnings Before Interest, Taxes, Depreciation, and Amortization | -$70.7M | -$77.73M | -$77.73M | -$165.84M |
| Effective Tax Rate | -0.14% | 0.37% | 0.37% | 0.91% |
FAQs
Risk Warning
Stock prices can be highly volatile and may rise or fall sharply in a short period. Digital asset and derivative products involve additional risks such as leverage and liquidity. Content on this page is for reference only and does not constitute investment advice. Product availability and access may vary by region and applicable regulations.